Amelia™-1 Study is testing if evexomostat can improve patients' safety and clinical response to a PI3K inhibitor plus an estrogen receptor degrader. Evexomostat, a novel MetAP2 inhibitor, controlled PI3K-induced hyperglycemia in the first study patient, consistent with pre-clinical data. Further, ctDNA data shows no evidence of residual PIK3CA mutation in blood after 6 weeks of treatment.
Read MoreThe American Academy of Cosmetic Surgery Hospital is to host 4 live surgery workshops as part of the fifth International Congress in Aesthetic, Anti-Aging Medicine and Medical SPA (ICAAM Middle East 2012) to be held on 23rdand 24th Novemb
Read MoreThe self defense products website will participate in the festivities this Saturday the 13th in Fort Lauderdale, Florida. WomenOnGuard.com will be selling their pink self defense products. A portion will go toward the fight against Breast Cancer.
Read MoreSupport Connection, a non-profit organization offering free support services for people affected by breast & ovarian cancer, launches a new monthly support group for women living with breast cancer later in life.
Read MoreCalifornia in 2009 raised the age at which women qualify for free breast cancer screening, from 40 years old to 50. Finding this change unacceptable, Santa Barbara Neighborhood Clinics and Sansum Clinic have stepped into the breach.
Read MoreWomen's health is in fact an issue that surrounds all aspects of women's life; it ranges from pre pubertal to post menopausal conditions. These issues include onset of puberty, contraception, pregnancy, child birth, breast and female genital heal
Read More